Assessment of FreeStyle Libre Flash Glucose Monitoring System Implementation in Real Life Clinical Setting: A Prospective Observational Study.

FreeStyle Libre diabetes type 1 education glycemic control real life settings

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
13 Feb 2021
Historique:
received: 22 12 2020
revised: 28 01 2021
accepted: 10 02 2021
entrez: 6 3 2021
pubmed: 7 3 2021
medline: 7 3 2021
Statut: epublish

Résumé

In this study, we investigated the effectiveness of FreeStyle Libre Flash Glucose Monitoring (FGM) implementation in a real life clinical setting with the emphasis on the effect of initial education on the use of the FGM system. This prospective observational study included 425 diabetes type 1 subjects followed up for 3 to 12 months (320 were followed up to 3 months, 267 up to 6 months and 147 up to period of one year). An FGM sensor was placed at study entry and all participants were educated through a period of 5 days on sensor usage and self-management of glycemia with follow up visits every 3 months. HbA1c values significantly decreased from baseline (T0) to 3 months (T3) ( The improvement in HbA1c was mainly driven by the increase in the number of scans per day. The subjects with poorer glycemic control and those who seldom performed SMBG benefited the most.

Sections du résumé

BACKGROUND BACKGROUND
In this study, we investigated the effectiveness of FreeStyle Libre Flash Glucose Monitoring (FGM) implementation in a real life clinical setting with the emphasis on the effect of initial education on the use of the FGM system.
METHODS METHODS
This prospective observational study included 425 diabetes type 1 subjects followed up for 3 to 12 months (320 were followed up to 3 months, 267 up to 6 months and 147 up to period of one year). An FGM sensor was placed at study entry and all participants were educated through a period of 5 days on sensor usage and self-management of glycemia with follow up visits every 3 months.
RESULTS RESULTS
HbA1c values significantly decreased from baseline (T0) to 3 months (T3) (
CONCLUSIONS CONCLUSIONS
The improvement in HbA1c was mainly driven by the increase in the number of scans per day. The subjects with poorer glycemic control and those who seldom performed SMBG benefited the most.

Identifiants

pubmed: 33668675
pii: diagnostics11020305
doi: 10.3390/diagnostics11020305
pmc: PMC7918764
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Cardiovasc Endocrinol Metab. 2020 Jun 16;9(4):171-176
pubmed: 33225233
Aust J Rural Health. 2018 Dec;26(6):453-454
pubmed: 30450604
J Diabetes Complications. 2020 Jun;34(6):107559
pubmed: 32089428
Endocrinol Diabetes Metab. 2018 Jun 17;1(3):e00023
pubmed: 30815557
Diabetes Care. 2013 Jul;36(7):2009-14
pubmed: 23378621
Diabet Med. 2018 Apr;35(4):483-490
pubmed: 29230878
Diabetes Res Clin Pract. 2019 Nov;157:107893
pubmed: 31669628
Diabet Med. 2018 Apr;35(4):472-482
pubmed: 29356072
Diabetes Res Clin Pract. 2018 Mar;137:37-46
pubmed: 29278709
Diabet Med. 2017 May;34(5):732
pubmed: 28103416
Diabetes Ther. 2017 Jun;8(3):573-586
pubmed: 28401454
J Diabetes Sci Technol. 2017 Mar;11(2):442-443
pubmed: 27464754
Diabetes Technol Ther. 2019 Jul;21(7):409-412
pubmed: 31265349
Diabetes Care. 2019 Aug;42(8):1593-1603
pubmed: 31177185
Lancet. 2016 Nov 5;388(10057):2254-2263
pubmed: 27634581
J Diabetes Sci Technol. 2013 Mar 01;7(2):562-78
pubmed: 23567014
Exp Clin Endocrinol Diabetes. 2019 Jun 11;:
pubmed: 31185506
Diabetologia. 2019 Aug;62(8):1349-1356
pubmed: 31177314
Diabetes Care. 2019 Jul;42(7):1178-1184
pubmed: 31036546
J Diabetes Sci Technol. 2016 Nov 1;10(6):1412-1413
pubmed: 27277660
Endocrinol Diabetes Nutr. 2018 Dec;65(10):556-563
pubmed: 29907546
BMJ Open Diabetes Res Care. 2017 Apr 6;5(1):e000342
pubmed: 28611921

Auteurs

Silvija Canecki Varzic (S)

Department of Endocrinology and Metabolism Disorders, Clinical Hospital Center Osijek, 31000 Osijek, Croatia.
Faculty of Medicine, University J.J.Strossmayer, 31000 Osijek, Croatia.

Kristina Steiner (K)

Department of Endocrinology and Metabolism Disorders, Clinical Hospital Center Osijek, 31000 Osijek, Croatia.

Maja Gradinjan Centner (M)

Department of Endocrinology and Metabolism Disorders, Clinical Hospital Center Osijek, 31000 Osijek, Croatia.

Mladen Grgurevic (M)

Vuk Vrhovac University Clinic for Diabetes, Endocrinology and Metabolic Diseases, Merkur University Hospital, Dugi dol 4a, 10000 Zagreb, Croatia.

Maja Cigrovski Berkovic (M)

Department for Endocrinology, Diabetes and Metabolism Clinical Hospital Dubrava, 10000 Zagreb, Croatia.

Sanja Klobucar Majanovic (S)

Department for Endocrinology, Diabetes and Metabolism University Hospital Center Rijeka, 51000 Rijeka, Croatia.

Maja Radman (M)

Department for Endocrinology, Diabetes and Metabolism University Hospital Center Split, 21000 Split, Croatia.

Tanja Milicevic (T)

Department for Endocrinology, Diabetes and Metabolism University Hospital Center Split, 21000 Split, Croatia.

Dario Rahelic (D)

Vuk Vrhovac University Clinic for Diabetes, Endocrinology and Metabolic Diseases, Merkur University Hospital, Dugi dol 4a, 10000 Zagreb, Croatia.

Ines Bilic Curcic (I)

Department of Endocrinology and Metabolism Disorders, Clinical Hospital Center Osijek, 31000 Osijek, Croatia.
Faculty of Medicine, University J.J.Strossmayer, 31000 Osijek, Croatia.

Classifications MeSH